Rimonabant leads to modest weight loss,Cochrane review concludes

摘要

Use of rimonabant for one year could produce moderate weight loss of about 5 per cent,according to a Cochrane review of the anti-obesity drug,which was launched in the UK earlier this year (PJ,1 July,p8).However,the review,published online on 18 October (www.thecochranelibrary.com),concludes that more rigorous studies are needed to evaluate fully the benefit/risk ratio of rimonabant.